Outlier test for reference replicate crossover study design [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2019-08-13 17:28 (1322 d 05:19 ago) – Posting: # 20495
Views: 1,797

Hi Abhimanyu,

❝ I have question regarding outlier test (Using Lund's method) for reference replicate crossover study design.


Sounds like a bad idea.

❝ How can we find outlier? which one will be appropriate scenario for any regulatory point of view?


The trick is to avoid generating outliers. In my small universe, there is no problem that merits a solution involving identification and and removal of outliers.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,553 posts in 4,724 threads, 1,606 registered users;
16 visitors (0 registered, 16 guests [including 8 identified bots]).
Forum time: 22:47 CEST (Europe/Vienna)

Learning of many things
does not teach intelligence.    Heraclitus of Ephesus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5